Science-advisor
REGISTER info/FAQ
Login
username
password
     
forgot password?
register here
 
Research articles
  search articles
  reviews guidelines
  reviews
  articles index
My Pages
my alerts
  my messages
  my reviews
  my favorites
 
 
Stat
Members: 3645
Articles: 2'504'928
Articles rated: 2609

25 April 2024
 
  » pubmed » pmid10408445

 Article overview



Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse
D Schenk ; R Barbour ; W Dunn ; G Gordon ; H Grajeda ; T Guido ; K Hu ; J Huang ; K Johnson-Wood ; K Khan ; D Kholodenko ; M Lee ; Z Liao ; I Lieberburg ; R Motter ; L Mutter ; F Soriano ; G Shopp ; N Vasquez ; C Vandevert ; S Walker ; M Wogulis ; T Yednock ; D Games ; P Seubert ;
Date 8 Jul 1999
Journal Nature, 400 (6740), 173-7
AbstractAmyloid-beta peptide (Abeta) seems to have a central role in the neuropathology of Alzheimer’s disease (AD). Familial forms of the disease have been linked to mutations in the amyloid precursor protein (APP) and the presenilin genes. Disease-linked mutations in these genes result in increased production of the 42-amino-acid form of the peptide (Abeta42), which is the predominant form found in the amyloid plaques of Alzheimer’s disease. The PDAPP transgenic mouse, which overexpresses mutant human APP (in which the amino acid at position 717 is phenylalanine instead of the normal valine), progressively develops many of the neuropathological hallmarks of Alzheimer’s disease in an age- and brain-region-dependent manner. In the present study, transgenic animals were immunized with Abeta42, either before the onset of AD-type neuropathologies (at 6 weeks of age) or at an older age (11 months), when amyloid-beta deposition and several of the subsequent neuropathological changes were well established. We report that immunization of the young animals essentially prevented the development of beta-amyloid-plaque formation, neuritic dystrophy and astrogliosis. Treatment of the older animals also markedly reduced the extent and progression of these AD-like neuropathologies. Our results raise the possibility that immunization with amyloid-beta may be effective in preventing and treating Alzheimer’s disease.
Source PubMed, pmid10408445 doi: 10.1038/22124
Services Forum | Review | Favorites   
 
Visitor rating: did you like this article? no 1   2   3   4   5   yes

No review found.
 Did you like this article?

This article or document is ...
important:
of broad interest:
readable:
new:
correct:
Global appreciation:

  Note: answers to reviews or questions about the article must be posted in the forum section.
Authors are not allowed to review their own article. They can use the forum section.

browser Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)






ScienXe.org
» my Online CV
» Free


News, job offers and information for researchers and scientists:
home  |  contact  |  terms of use  |  sitemap
Copyright © 2005-2024 - Scimetrica